Lipedema and EDS — Understanding a Common Overlap

Ehlers-Danlos Syndrome (EDS) and lipedema are two conditions that are frequently misunderstood individually — and even more frequently unrecognised when they occur together. Yet clinical observations and patient surveys suggest the overlap between the two is significant. Understanding the connection matters not only for diagnosis but for how you manage both conditions at the same time.

What is Ehlers-Danlos Syndrome?

Ehlers-Danlos Syndrome is a group of inherited connective tissue disorders caused by abnormalities in the structure or production of collagen — the protein that provides structure and elasticity to skin, joints, blood vessels, and other tissues. There are thirteen recognised subtypes, ranging from the rare and life-threatening vascular type to the far more common hypermobile type.

Hypermobile EDS (hEDS) is the most prevalent subtype. It is characterised by:

• Joint hypermobility (joints that move beyond the normal range)
• Joint instability, dislocation, and chronic pain
• Soft, stretchy, or fragile skin
• Easy bruising
• Fatigue — often profound and disproportionate to activity level
• Autonomic dysfunction (palpitations, dizziness on standing, temperature dysregulation)
• Gastrointestinal issues including motility problems

Unlike most other EDS subtypes, hEDS does not have a confirmed genetic marker and is diagnosed clinically using the 2017 international diagnostic criteria.

Hypermobility spectrum disorder (HSD) occupies a related category — people who have clinically significant joint hypermobility and associated symptoms that do not fully meet hEDS criteria. HSD and hEDS are now understood to exist on a spectrum rather than as distinct categories.

Why lipedema and hEDS frequently occur together

The exact reason for the overlap between lipedema and hypermobile EDS is not fully established, but several hypotheses are supported by clinical observations. Research published by Buso et al. (2019) in Obesity and subsequent work by lipedema specialists have highlighted elevated rates of hypermobility and connective tissue features among women diagnosed with lipedema, suggesting a biological link rather than coincidental co-occurrence.

Shared connective tissue involvement

Both conditions involve connective tissue. Lipedema is characterised by abnormal subcutaneous adipose tissue with fibrosis, increased vascular permeability, and altered connective tissue architecture. EDS involves abnormal collagen. It is plausible that shared or related connective tissue vulnerabilities contribute to both conditions appearing in the same individual.

Shared hormonal sensitivity

Both lipedema and hEDS disproportionately affect women and both appear to be influenced by oestrogen. Lipedema typically onset or worsens significantly during puberty, pregnancy, and menopause — periods of hormonal change. EDS symptoms similarly fluctuate with the menstrual cycle in many women, with joint laxity and pain often worsening in the premenstrual phase.

Lymphatic involvement in both

EDS is increasingly recognised to involve lymphatic and vascular abnormalities. The connective tissue that comprises lymphatic vessel walls is affected by abnormal collagen, potentially contributing to lymphatic insufficiency. Lipedema itself involves abnormal lymphatic function in later stages. Where both conditions are present, lymphatic compromise may be more pronounced.

What the overlap looks like clinically

Women living with both lipedema and hEDS often describe a clinical picture that is more complex than either condition alone:

• Pain that is more widespread — the joint and connective tissue pain of EDS on top of the painful fat and tissue hypersensitivity of lipedema
• Fatigue that is more severe and harder to manage
• Exercise that is both necessary (for lymphatic drainage and joint stability) and harder to tolerate (due to joint pain, post-exertional malaise, and lipedema-related heaviness)
• Difficulty with compression garments — fragile skin, vascular laxity, and dysautonomia can all affect tolerability
• Greater sensitivity to temperature changes and hormonal fluctuation

Misdiagnosis is common. Joint pain and easy bruising can be attributed to lipedema alone. Swelling and heaviness can be attributed to EDS-related fluid dysregulation alone. When clinicians are not looking for both, one condition often explains away the other.

Why this matters for management

The coexistence of lipedema and hEDS changes how treatment should be approached in several important ways.

Exercise selection

Exercise is a cornerstone of both conditions — but the type matters significantly when both are present. High-impact and weight-bearing exercise that hypermobile joints tolerate poorly (running, jumping, heavy lifting) is also often poorly tolerated by lipedema-affected limbs. Water-based exercise — swimming, aqua aerobics, aqua walking — is frequently recommended for both conditions because it supports joint stability through buoyancy while providing resistance and lymphatic stimulation. See water exercise and lipedema for more.

Compression

Compression is a primary conservative treatment for lipedema and lymphatic drainage. When hEDS is also present, skin fragility, hypersensitivity, and vascular laxity may affect which garments are tolerable and how they are worn. Flat-knit compression is generally better tolerated than circular-knit for people with fragile or reactive skin.

Pain management

The interaction of lipedema pain (tissue hypersensitivity, inflammation) and EDS pain (joint instability, nerve involvement, widespread musculoskeletal pain) often requires a more nuanced approach than either diagnosis alone suggests. Standard lipedema pain management — anti-inflammatory diet, compression, movement, heat/cold — addresses some but not all of the pain burden when EDS is also present.

Appointment preparation

Seeing clinicians for both conditions requires clear, documented symptom histories. Pain that moves (EDS joint pain) and pain that is localised to lipedema regions are different, but they overlap and can be confusing to describe from memory. A consistent symptom log that records both the type and location of pain, daily severity, and relevant factors (activity, cycle phase, compression use) helps clinicians understand what they are working with. See lipedema appointment preparation for guidance on building this record.

Getting both conditions recognised

If you suspect you have both conditions, raising each with a clinician who has knowledge of both is the most direct path. In practice, this often means:

• A lipedema specialist for the adipose tissue diagnosis
• A rheumatologist, geneticist, or hypermobility-aware physiotherapist for the EDS assessment
• Clear symptom documentation that covers both conditions over time

Bringing a structured symptom record to these appointments — one that captures not just lipedema symptoms but joint pain, fatigue, and other systemic symptoms — makes the case for both diagnoses more visible and easier for clinicians to act on.

Frequently asked questions

What is the connection between lipedema and Ehlers-Danlos Syndrome? Both lipedema and hypermobile Ehlers-Danlos Syndrome (hEDS) are connective tissue-related conditions that disproportionately affect women, involve shared hormonal sensitivities, and are frequently underdiagnosed. Clinical observations and patient community data suggest that having one increases the likelihood of having the other, though the precise genetic or mechanistic link is not yet fully established. Many women receive one diagnosis and later discover the other.

How do I know if I have both lipedema and EDS? Symptoms that suggest EDS may coexist with lipedema include: joint hypermobility (joints that bend further than normal), history of frequent joint dislocations or sprains, chronic widespread musculoskeletal pain beyond the lipedema-affected areas, stretchy or fragile skin, easy bruising beyond what lipedema typically explains, profound fatigue, and autonomic symptoms like dizziness on standing. If these features are present alongside confirmed or suspected lipedema, raising EDS assessment with a knowledgeable clinician is worthwhile.

Does having EDS make lipedema worse? Having both conditions typically makes the clinical picture more complex and the symptom burden greater than either condition alone. Joint instability limits exercise tolerance, increasing the challenge of movement-based lymphatic support. Pain from both sources overlaps and compounds. EDS-related fatigue adds to the fatigue already associated with lipedema. Managing both conditions simultaneously requires a more tailored conservative care approach than managing either alone.

Can you have lipedema without EDS and EDS without lipedema? Yes. The two conditions are distinct, and most people with one do not have the other. However, the overlap rate appears to be higher than would be expected by chance, which is why awareness of both is important when either is diagnosed.

Is there a test for Ehlers-Danlos Syndrome? For hypermobile EDS (hEDS) — the most common type and the one most associated with lipedema overlap — there is currently no confirmed genetic marker. Diagnosis is clinical, based on the 2017 international criteria, which assess joint hypermobility, skin characteristics, systemic features, family history, and the absence of alternative diagnoses. For most other EDS subtypes, genetic testing is available and recommended. Referral to a rheumatologist or clinical geneticist with hypermobility expertise is the appropriate pathway.

This article is for informational purposes only and does not constitute medical advice. If you believe you may have Ehlers-Danlos Syndrome, lipedema, or both, please seek assessment from qualified healthcare providers with experience in these conditions.